How to cite Canada Peptides reference standards
Methods sections work best when another lab can identify the exact material used. For a reference standard, the supplier name alone is not enough. A useful citation includes the molecule name, catalog ID, supplier, location, lot-specific COA where relevant, and a registry identifier when one has been issued.
Canonical citation format
[Reference standard name] ([SKU]; Canada Peptides Inc., Toronto, ON, Canada; RRID:SCR_XXXXXXX)
Use the RRID only after it has been assigned and resolves in the RRID portal. Until then, use the SKU and supplier line without an RRID.
Example
Semaglutide reference standard (CP-001; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) was reconstituted according to the study protocol and verified against the lot Certificate of Analysis.
Per-SKU citation table
Copy a methods-ready citation for any catalog SKU. Three SKUs are pending chemistry verification and should not be cited as RRID-ready.
| SKU | Product | MW | RRID status | |
|---|---|---|---|---|
| CP-001 | Semaglutide | 4113.6 | RRID pending | Semaglutide reference standard (CP-001; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-002 | Tirzepatide | 4813.5 | RRID pending | Tirzepatide reference standard (CP-002; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-003 | Retatrutide | 4731.4 | RRID pending | Retatrutide reference standard (CP-003; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-004 | 5-Amino-1MQ | 159.2 | RRID pending | 5-Amino-1MQ reference standard (CP-004; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-005 | AOD-9604 | 1817.1 | RRID pending | AOD-9604 reference standard (CP-005; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-006 | SLU-PP-332 | pending | PENDING CHEMISTRY — DO NOT CITE | |
| CP-010 | CJC-1295 No-DAC | 3367.9 | RRID pending | CJC-1295 No-DAC reference standard (CP-010; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-011 | CJC-1295 DAC | 3647.9 | RRID pending | CJC-1295 DAC reference standard (CP-011; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-012 | Ipamorelin | 711.9 | RRID pending | Ipamorelin reference standard (CP-012; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-013 | Hexarelin | 887.1 | RRID pending | Hexarelin reference standard (CP-013; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-014 | GHRP-2 | 817.9 | RRID pending | GHRP-2 reference standard (CP-014; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-015 | GHRP-6 | 872 | RRID pending | GHRP-6 reference standard (CP-015; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-016 | MK-677 (Ibutamoren) | 528.7 | RRID pending | MK-677 (Ibutamoren) reference standard (CP-016; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-017 | Sermorelin | 3357.9 | RRID pending | Sermorelin reference standard (CP-017; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-018 | Tesamorelin | 5135.9 | RRID pending | Tesamorelin reference standard (CP-018; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-020 | Selank | 751.9 | RRID pending | Selank reference standard (CP-020; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-021 | N-Acetyl Selank | 793.9 | RRID pending | N-Acetyl Selank reference standard (CP-021; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-022 | Semax | 813.9 | RRID pending | Semax reference standard (CP-022; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-023 | Cerebrolysin Fragment | pending | RRID pending | Cerebrolysin Fragment reference standard (CP-023; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-024 | P21 (Cerepro) | 1340.4 | RRID pending | P21 (Cerepro) reference standard (CP-024; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-025 | Dihexa | 535.7 | PENDING CHEMISTRY — DO NOT CITE | |
| CP-030 | BPC-157 | 1419.5 | RRID pending | BPC-157 reference standard (CP-030; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-031 | TB-500 (Acetylated Thymosin Beta-4) | 4963.4 | RRID pending | TB-500 (Acetylated Thymosin Beta-4) reference standard (CP-031; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-032 | BPC-157 Arginate | 1497.6 | PENDING CHEMISTRY — DO NOT CITE | |
| CP-033 | KPV | 401.5 | RRID pending | KPV reference standard (CP-033; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-034 | LL-37 | 4493.3 | RRID pending | LL-37 reference standard (CP-034; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-035 | GHK-Cu | 402.9 | RRID pending | GHK-Cu reference standard (CP-035; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-040 | Epitalon | 390.4 | RRID pending | Epitalon reference standard (CP-040; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-041 | NAD+ (lyophilized) | 663.4 | RRID pending | NAD+ (lyophilized) reference standard (CP-041; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-042 | Humanin | 2687.2 | RRID pending | Humanin reference standard (CP-042; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-043 | MOTS-c | 2174.6 | RRID pending | MOTS-c reference standard (CP-043; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-044 | SS-31 (Elamipretide) | 639.8 | RRID pending | SS-31 (Elamipretide) reference standard (CP-044; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-045 | Thymosin Alpha-1 | 3108.3 | RRID pending | Thymosin Alpha-1 reference standard (CP-045; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-050 | Melanotan II | 1024.2 | RRID pending | Melanotan II reference standard (CP-050; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-051 | Melanotan I (Afamelanotide) | 1646.9 | RRID pending | Melanotan I (Afamelanotide) reference standard (CP-051; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-052 | PT-141 (Bremelanotide) | 1025.2 | RRID pending | PT-141 (Bremelanotide) reference standard (CP-052; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-060 | Argireline | 888.9 | RRID pending | Argireline reference standard (CP-060; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-061 | Matrixyl | 802 | RRID pending | Matrixyl reference standard (CP-061; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-062 | SNAP-8 | 1075.2 | RRID pending | SNAP-8 reference standard (CP-062; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-070 | Repair Stack (BPC-157 + TB-500) | pending | RRID pending | Repair Stack (BPC-157 + TB-500) reference standard (CP-070; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
| CP-071 | Wellness Stack (CJC-1295 + Ipamorelin) | pending | RRID pending | Wellness Stack (CJC-1295 + Ipamorelin) reference standard (CP-071; Canada Peptides Inc., Toronto, ON, Canada; RRID pending) |
Research guide citation format
Canada Peptides Scientific Team. [Article title]. Canada Peptides Research Guide. [URL]. Accessed [date].
Acknowledgement format
The authors thank Canada Peptides Inc. for lot-level Certificate of Analysis documentation and methods-section citation support. Canada Peptides had no role in study design, data analysis, or manuscript conclusions.